Form Type: 4

SEC EDGAR Link
Accession Number:0001415889-21-003584
Date:2021-07-08
Issuer: IDERA PHARMACEUTICALS, INC. (IDRA)
Original Submission Date:

Reporting Person:

KIRBY JOHN J.
C/O IDERA PHARMACEUTICALS, INC.
505 EAGLEVIEW BOULEVARD, SUITE 212 EXTON, PA 19341

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION (RIGHT TO BUY) 1.11 2021-07-08 deemed execution date A 66,500 (a) 2031-07-08 common stock 66,500 $1.11 66,500 direct
Footnotes
IDfootnote
f1 the stock option award was granted under the issuer's 2013 stock incentive plan. the stock option vests and becomes exercisable over a four-year period commencing on july 8, 2021. twenty-five percent (25%) of the stock option vests and becomes exercisable on july 8, 2022 (first anniversary of the date of grant) and the balance vests in twelve equal quarterly installments over the remaining three years of the four-year period, subject to continued service with the issuer.

Elevate your investments